Request Deal Involvement

Hypera completed the acquisition of selected OTC assets of Takeda Pharmaceutical for $825m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Cescon Barrieu Flesch & Barreto

legal advisors

Cescon Barrieu Flesch & Barreto

Lobo de Rizzo

legal advisors

Lobo de Rizzo

White & Case

legal advisors

White & Case

or

Principals

HYPERA SA

bidder

HYPERA SA

TAKEDA PHARMACEUTICAL COMPANY LIMITED (SELECTED OTC ASSETS)

target

TAKEDA PHARMACEUTICAL COMPANY LIMITED (SELECTED OTC ASSETS)

TAKEDA PHARMACEUTICAL COMPANY LIMITED

vendor

TAKEDA PHARMACEUTICAL COMPANY LIMITED

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Hypera completed the acquisition of selected OTC assets of Takeda Pharmaceutical for $825m.